Cargando…

4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial

Detalles Bibliográficos
Autores principales: Rodriguez, R., Nichol, G., Eucker, S., Chang, A.M., Arreguin, M., Morse, D., Shughart, L., Pauley, A., Eswaran, V., O'Laughlin, K., Chavez, C.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519207/
http://dx.doi.org/10.1016/j.annemergmed.2022.08.026
_version_ 1784799343936536576
author Rodriguez, R.
Nichol, G.
Eucker, S.
Chang, A.M.
Arreguin, M.
Morse, D.
Shughart, L.
Pauley, A.
Eswaran, V.
O'Laughlin, K.
Chavez, C.L.
author_facet Rodriguez, R.
Nichol, G.
Eucker, S.
Chang, A.M.
Arreguin, M.
Morse, D.
Shughart, L.
Pauley, A.
Eswaran, V.
O'Laughlin, K.
Chavez, C.L.
author_sort Rodriguez, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9519207
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95192072022-09-29 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial Rodriguez, R. Nichol, G. Eucker, S. Chang, A.M. Arreguin, M. Morse, D. Shughart, L. Pauley, A. Eswaran, V. O'Laughlin, K. Chavez, C.L. Ann Emerg Med Article Published by Mosby, Inc. 2022-10 2022-09-29 /pmc/articles/PMC9519207/ http://dx.doi.org/10.1016/j.annemergmed.2022.08.026 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rodriguez, R.
Nichol, G.
Eucker, S.
Chang, A.M.
Arreguin, M.
Morse, D.
Shughart, L.
Pauley, A.
Eswaran, V.
O'Laughlin, K.
Chavez, C.L.
4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title_full 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title_fullStr 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title_full_unstemmed 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title_short 4 COVID-19 Vaccine Messaging Platforms Increase Vaccine Acceptance and Uptake in Unvaccinated Emergency Department Patients: A Cluster Randomized Controlled Trial
title_sort 4 covid-19 vaccine messaging platforms increase vaccine acceptance and uptake in unvaccinated emergency department patients: a cluster randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519207/
http://dx.doi.org/10.1016/j.annemergmed.2022.08.026
work_keys_str_mv AT rodriguezr 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT nicholg 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT euckers 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT changam 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT arreguinm 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT morsed 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT shughartl 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT pauleya 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT eswaranv 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT olaughlink 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial
AT chavezcl 4covid19vaccinemessagingplatformsincreasevaccineacceptanceanduptakeinunvaccinatedemergencydepartmentpatientsaclusterrandomizedcontrolledtrial